Characterization of a double-hit murine model of acute respiratory distress syndrome

Clinical and Experimental Pharmacology and Physiology

Volumn 41, Issue 10, 2014, Pages 844-853

  Voelker, Maria Theresa ^a   Fichtner, Falk ^a   Kasper, Michael ^b   Kamprad, Manja ^a   Sack, Ulrich ^a   Kaisers, Udo X ^a   Laudi, Sven ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Animal models; Inflammation; Mouse model; Murine

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; KERATINOCYTE CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; OLEIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; LIPOPOLYSACCHARIDE;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTICLE; CAPILLARY WALL; CONTROLLED STUDY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LUNG HEMODYNAMICS; LUNG PARENCHYMA; LUNG WEIGHT; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NEUTROPHIL; NONHUMAN; PRACTICE GUIDELINE; ANIMAL; BLOOD; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; HEMODYNAMICS; LUNG; LUNG EDEMA; PATHOLOGY; PROCEDURES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; HEMODYNAMICS; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; OLEIC ACID; PULMONARY EDEMA; RESPIRATORY DISTRESS SYNDROME, ADULT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; X-RAY MICROTOMOGRAPHY;

EID: 84911119773     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12283     Document Type: Article

References (50)

1. Rubenfeld GD, Caldwell E, Peabody E et al. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 2005; 353: 1685-93.
2. Phua J, Badia JR, Adhikari NK et al. Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am. J. Respir. Crit. Care Med. 2009; 179: 220-7.
3. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967; 2: 319-23.
4. Artigas A, Bernard GR, Carlet J et al. The American-European Consensus Conference on ARDS, part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodeling. Intensive Care Med. 1998; 24: 378-98.
5. Bernard GR, Artigas A, Brigham KL et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 1994; 149: 818-24.
6. Rubenfeld GD. Acute respiratory distress syndrome: The Berlin definition. JAMA 2012; 307: 2526-33.
7. Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008; 295: L379-99.
8. Wang HM, Bodenstein M, Markstaller K. Overview of the pathology of three widely used animal models of acute lung injury. Eur. Surg. Res. 2008; 40: 305-16.
9. Bastarache JA, Blackwell TS. Development of animal models for the acute respiratory distress syndrome. Dis. Model. Mech. 2009; 2: 218-23.
10. Martin TR, Matute-Bello G. Experimental models and emerging hypotheses for acute lung injury. Crit. Care Clin. 2011; 27: 735-52.
11. Matute-Bello G, Downey G, Moore BB et al. An official American Thoracic Society workshop report: Features and measurements of experimental acute lung injury in animals. Am. J. Respir. Cell Mol. Biol. 2010; 44: 725-38.
12. Ulrich K, Stern M, Goddard ME et al. Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005; 288: L1179-92.
13. Zhou Z, Kozlowski J, Schuster DP. Physiologic, biochemical, and imaging characterization of acute lung injury in mice. Am. J. Respir. Crit. Care Med. 2005; 172: 344-51.
14. Petersen B, Bloch KD, Ichinose F et al. Activation of Toll-like receptor 2 impairs hypoxic pulmonary vasoconstriction in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008; 294: L300-8.
15. Hedlund LW, Vock P, Effmann EL, Putman CE. Morphology of oleic acid-induced lung injury. Observations from computed tomography, specimen radiography, and histology. Invest. Radiol. 1985; 20: 2-8.
16. Brimioulle S, Julien V, Gust R, Kozlowski JK, Naeije R, Schuster DP. Importance of hypoxic vasoconstriction in maintaining oxygenation during acute lung injury. Crit. Care Med. 2002; 30: 874-80.
17. Ghosh S, Wilson MR, Choudhury S et al. Effects of inhaled carbon monoxide on acute lung injury in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005; 288: L1003-9.
18. Wang L, Zhu DM, Su X, Bai CX, Ware LB, Matthay MA. Acute cardiopulmonary effects of a dual-endothelin receptor antagonist on oleic acid-induced pulmonary arterial hypertension in dogs. Exp. Lung Res. 2004; 30: 31-42.
19. Xu RF, Li TT, Feng XY et al. Therapeutic effect of hyperoxygenated solution on acute lung injury induced by oleic acid. Eur. Surg. Res. 2008; 41: 37-43.
20. Gaio E, de Melo e Silva CA, Brito F, Firmino MA, Storck R, Freitas E. Stability of the animal model of oleic acid-induced acute lung injury. J. Bras. Pneumol. 2009; 35: 759-66.
21. Gust R, Kozlowski J, Stephenson AH, Schuster DP. Synergistic hemodynamic effects of low-dose endotoxin and acute lung injury. Am. J. Respir. Crit. Care Med. 1998; 157: 1919-26.
22. Schuster DP, Kozlowski JK, McCarthy T, Morrow J, Stephenson A. Effect of endotoxin on oleic acid lung injury does not depend on priming. J. Appl. Physiol. 2001; 91: 2047-54.
23. Brigham KL. Mechanisms of lung injury. Clin. Chest Med. 1982; 3: 9-24.
24. Pratt PC, Vollmer RT, Shelburne JD, Crapo JD. Pulmonary morphology in a multihospital collaborative extracorporeal membrane oxygenation project. I. Light microscopy. Am. J. Pathol. 1979; 95: 191-214.
25. McElroy MC, Kasper M. The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair. Eur. Respir. J. 2004; 24: 664-73.
26. Navarro A, Perez RE, Rezaiekhaligh M, Mabry SM, Ekekezie II. T1alpha/podoplanin is essential for capillary morphogenesis in lymphatic endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008; 295: L543-51.
27. Pastva AM, Wright JR, Williams KL. Immunomodulatory roles of surfactant proteins A and D. Implications in lung disease. Proc. Am. Thorac. Soc. 2007; 4: 252-7.
28. Ware LB, Koyama T, Billheimer DD et al. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 2009; 137: 288-96.
29. Kasper M. Phenotypic characterization of pulmonary arteries in normal and diseased lung. Chest 2005; 128(Suppl.): S547-52.
30. Testa JE, Chrastina A, Li Y, Oh P, Schnitzer JE. Ubiquitous yet distinct expression of podocalyxin on vascular surfaces in normal and tumor tissues in the rat. J. Vasc. Res. 2009; 46: 311-24.
31. Galani V, Tatsaki E, Bai M et al. The role of apoptosis in the pathophysiology of acute respiratory distress syndrome (ARDS): An up-to-date cell-specific review. Pathol. Res. Pract. 2010; 206: 145-50.
32. Rojas M, Woods CR, Mora AL, Xu J, Brigham KL. Endotoxin-induced lung injury in mice: Structural, functional, and biochemical responses. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005; 288: L333-41.
33. Kabir K, Gelinas JP, Chen M et al. Characterization of a murine model of endotoxin-induced acute lung injury. Shock 2002; 17: 300-3.
34. Xu GL, Yao L, Rao SY, Gong ZN, Zhang SQ, Yu SQ. Attenuation of acute lung injury in mice by oxymatrine is associated with inhibition of phosphorylated p38 mitogen-activated protein kinase. J. Ethnopharmacol. 2005; 98: 177-83.
35. Kingsmore SF. Multiplexed protein measurement. Technologies and applications of protein and antibody arrays. Nat. Rev. Drug Discov. 2006; 5: 310-20.
36. McDuffie E, Obert L, Chupka J, Sigler R. Detection of cytokine protein expression in mouse lung homogenates using suspension bead array. J. Inflamm. 2006; 3: 15.
37. Vainio O. Introduction to the clinical pharmacology of medetomidine. Acta Vet. Scand. Suppl. 1989; 85: 85-8.
38. Zuurbier CJ, Emons VM, Ince C. Hemodynamics of anesthetized ventilated mouse models. Aspects of anesthetics, fluid support, and strain. Am. J. Physiol. Heart Circ. Physiol. 2002; 282: H2099-105.
39. Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J. Pathol. 2004; 202: 145-56.
40. Chen HI, Hsieh NK, Kao SJ, Su CF. Protective effects of propofol on acute lung injury induced by oleic acid in conscious rats. Crit. Care Med. 2008; 36: 1214-21.
41. Li T, Zhao B, Wang C et al. Regulatory effects of hydrogen sulfide on IL-6, IL-8 and IL-10 levels in the plasma and pulmonary tissue of rats with acute lung injury. Exp. Biol. Med. 2008; 233: 1081-7.
42. Osuchowski MF, Welch K, Siddiqui J, Remick DG. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J. Immunol. 2006; 177: 1967-74.
43. Suratt BT, Eisner MD, Calfee CS et al. Plasma granulocyte colony-stimulating factor levels correlate with clinical outcomes in patients with acute lung injury. Crit. Care Med. 2009; 37: 1322-8.
44. Wiedermann FJ, Mayr AJ, Kaneider NC, Fuchs D, Mutz NJ, Schobersberger W. Alveolar granulocyte colony-stimulating factor and alpha-chemokines in relation to serum levels, pulmonary neutrophilia, and severity of lung injury in ARDS. Chest 2004; 125: 212-19.
45. Matute-Bello G, Liles WC, Radella F 2nd et al. Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome. Crit. Care Med. 2000; 28: 1-7.
46. Aggarwal A, Baker CS, Evans TW, Haslam PL. G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome. Eur. Respir. J. 2000; 15: 895-901.
47. Pelaez A, Bechara RI, Joshi PC, Brown LA, Guidot DM. Granulocyte/macrophage colony-stimulating factor treatment improves alveolar epithelial barrier function in alcoholic rat lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004; 286: L106-11.
48. Cakarova L, Marsh LM, Wilhelm J et al. Macrophage tumor necrosis factor-alpha induces epithelial expression of granulocyte-macrophage colony-stimulating factor: Impact on alveolar epithelial repair. Am. J. Respir. Crit. Care Med. 2009; 180: 521-32.
49. Broccard AF, Shapiro RS, Schmitz LL, Ravenscraft SA, Marini JJ. Influence of prone position on the extent and distribution of lung injury in a high tidal Volume oleic acid model of acute respiratory distress syndrome. Crit. Care Med. 1997; 25: 16-27.
50. Yamada M, Kuwano K, Maeyama T et al. Dual-immunohistochemistry provides little evidence for epithelial-mesenchymal transition in pulmonary fibrosis. Histochem. Cell Biol. 2008; 129: 453-62.